PatientFi^®, a point of sale financing company that helps make elective procedures more affordable for patients, announces it has entered into a co-marketing agreement with Allergan Aesthetics, an AbbVie company, to provide financing options for patients interested in breast augmentation with Natrelle^® Breast Implants.

According to 117 of prospective breast augmentation patients, 85% agreed that a monthly payment plan would motivate them to schedule a surgery sooner. By way of this partnership, Natrelle^® breast augmentation patients will be able to finance their surgery via a monthly payment plan.

PatientFi^® is ranked highly amongst patients, most notably for its high approval rates, soft credit check application, friendly 0% APR promotional financing plans ranging from 6 to 24 months and its 5-star rated customer service. For medical providers, PatientFi^® offers a 100% digital, point of sale platform which allows provider staff to quickly process financing applications start to finish in just a few clicks. With highly competitive merchant processing fees and a quick and easy transaction portal, PatientFi^® helps medical providers promote and convert more elective procedures like breast augmentation by increasing patients’ ability to afford treatment and achieve the outcome they desire.

“We are thrilled to be partnering with Allergan Aesthetics to help provide a new approach to patient financing for women seeking Natrelle^® breast augmentation. Breast augmentation continues to see the highest demand among all surgical procedures performed by plastic surgeons. Removing the barrier of affordability for patients with our unique financing alternative creates a ‘win-win’ for medical providers and patients. Our partnership allows practices to address the unmet financial needs of many patients and in turn, grow their case volume,” says Todd Watts, PatientFi^® CEO & Co-Founder.

Read full article on Yahoo.com